<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Pan Afr Med J</journal-id>
      <journal-id journal-id-type="iso-abbrev">Pan Afr Med J</journal-id>
      <journal-id journal-id-type="publisher-id">PAMJ</journal-id>
      <journal-title-group>
        <journal-title>The Pan African Medical Journal</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1937-8688</issn>
      <publisher>
        <publisher-name>The African Field Epidemiology Network</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">27347282</article-id>
      <article-id pub-id-type="pmc">4907768</article-id>
      <article-id pub-id-type="publisher-id">PAMJ-23-193</article-id>
      <article-id pub-id-type="doi">10.11604/pamj.2016.23.193.8545</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Bacteremia due to <italic>Acinetobacter ursingii</italic> in infants: Reports of two cases</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Yakut</surname>
            <given-names>Nurhayat</given-names>
          </name>
          <xref ref-type="aff" rid="AF0001">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kepenekli</surname>
            <given-names>Eda Kadayifci</given-names>
          </name>
          <xref ref-type="aff" rid="AF0001">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Karaaslan</surname>
            <given-names>Ayse</given-names>
          </name>
          <xref ref-type="aff" rid="AF0001">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Atici</surname>
            <given-names>Serkan</given-names>
          </name>
          <xref ref-type="aff" rid="AF0001">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Akkoc</surname>
            <given-names>Gulsen</given-names>
          </name>
          <xref ref-type="aff" rid="AF0001">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Demir</surname>
            <given-names>Sevliya Ocal</given-names>
          </name>
          <xref ref-type="aff" rid="AF0001">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Soysal</surname>
            <given-names>Ahmet</given-names>
          </name>
          <xref ref-type="aff" rid="AF0001">1</xref>
          <xref ref-type="corresp" rid="cor1">&amp;</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bakir</surname>
            <given-names>Mustafa</given-names>
          </name>
          <xref ref-type="aff" rid="AF0001">1</xref>
        </contrib>
      </contrib-group>
      <aff id="AF0001"><label>1</label>Division of Pediatric Infectious Diseases, Department of Pediatrics, Marmara University School of Medicine, Istanbul, Turkey</aff>
      <author-notes>
        <corresp id="cor1"><label>&amp;</label>Corresponding author: Ahmet Soysal, Division of Pediatric Infectious Diseases, Department of Pediatrics, Marmara University School of Medicine, Istanbul, Turkey</corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>15</day>
        <month>4</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2016</year>
      </pub-date>
      <volume>23</volume>
      <elocation-id>193</elocation-id>
      <history>
        <date date-type="received">
          <day>02</day>
          <month>12</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>03</day>
          <month>4</month>
          <year>2016</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Nurhayat Yakut et al.</copyright-statement>
        <copyright-year>2016</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0/">
          <license-p>The Pan African Medical Journal - ISSN 1937-8688. This is an Open Access article distributed under the terms of the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p><italic>Acinetobacter ursingii</italic> is an aerobic, gram-negative, opportunistic microorganism which is rarely isolated among <italic>Acinetobacter</italic> species. We present two immunocompetent infants who developed bacteremia due to <italic>A. ursingii</italic>. The first patient is a two -month- old boy who had been hospitalized in pediatric surgery unit for suspected tracheo-esophageal fistula because of recurrent aspiration pneumonia unresponsive to antibiotic therapy. The second patient is a fourteen -month- old boy with prolonged vomiting and diarrhea. <italic>A. ursingii</italic> was isolated from their blood cultures. They were successfully treated with ampicillin-sulbactam. Although <italic>A. ursingii</italic> has recently been isolated from a clinical specimen; reports of infection with <italic>A. ursingii</italic> in children are rare. <italic>A. ursingii</italic> should be kept in mind as an opportunistic microorganism in children.</p>
      </abstract>
      <kwd-group>
        <kwd>Bacteremia</kwd>
        <kwd>
          <italic>acinetobacter ursingii</italic>
        </kwd>
        <kwd>child</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro" id="S0001">
      <title>Introduction</title>
      <p><italic>Acinetobacter</italic> species are the most common causative agents of health care associated infections such as meningitis, ventilator-associated pneumonia, endocarditis and catheter-related bacteremia [<xref rid="CIT0001" ref-type="bibr">1</xref>, <xref rid="CIT0002" ref-type="bibr">2</xref>]. Despite their low virulence, they have increasingly been recognized as opportunistic microorganisms particularly in hospitalized and immunocompromised patients. <italic>Acinetobacter</italic> species can be found widely in nature. The organism can be a part of the flora of the skin, the oral cavity and the upper respiratory, genital and gastrointestinal tracts. The skin may become a reservoir for <italic>Acinetobacter</italic> in hospitalized patients and health care provider [<xref rid="CIT0003" ref-type="bibr">3</xref>]. Patients who have undergone a tracheostomy are at particularly high risk for colonization by <italic>Acinetobacter</italic>. Because they survive on inanimate surfaces for a long-term, these microorganisms can be commonly found in the hospital environment, particularly in moist areas such as in humidifiers and ventilators. Colonized medical equipment such as respiratory equipment and intravenous catheters may be responsible from nosocomial outbreaks [<xref rid="CIT0004" ref-type="bibr">4</xref>]. Although <italic>A. ursingii</italic>, has recently been isolated from a clinical specimen, reports of infection with <italic>A. ursingii</italic> in children are rare [<xref rid="CIT0005" ref-type="bibr">5</xref>]. Herein we report two cases with bacteremia due to <italic>A. ursingii</italic> in immunocompetent infants who were successfully treated.</p>
    </sec>
    <sec id="S0002">
      <title>Patient and observation</title>
      <sec id="S20003">
        <title>Patient 1</title>
        <p>A two-month-old boy had been hospitalized in pediatric surgery unit for suspected tracheo-osefageal fistula. He was referred from another hospital with the diagnosis of recurrent aspiration pneumonia unresponsive to antibiotic therapy. On the admission, he had tachypnea and subfebrile fever on physical examination. Laboratory tests showed a white blood cell (WBC) of 10900/&#xB5;l, C-reactive protein (CRP) of 11.8 mg/L and normal biochemistry values. Peripheral blood culture was obtained. Twelve hours later, the BacT/Alert device (bioMeri&#xE8;ux, Marseille, France) gave a signal indicating a growth of microorganism. Gram staining was positive for gram-negative coccobacilli. The microorganism was nonmotile, strictly aerobic, catalase-positive and oxidase-negative. Empirical antibiotic treatment with meropenem and amikacin was started. The next day, Vitek MS (bioMeri&#xE8;ux, Marseille, France) identified the microorganism as <italic>Acinetobacter ursingii</italic> and reliability was 99.9%. The E-test used to describe antimicrobiological susceptibility showed that the microorganism was susceptible to ampicillin-sulbactam, gentamicin, ciprofloxacin and imipenem. The antibiotic therapy was de-escalated to ampicillin-sulbactam. On the third day of the treatment, control peripheral blood culture was taken and remained sterile. He was successfully treated with ampicillin-sulbactam.</p>
      </sec>
      <sec id="S20004">
        <title>Patient 2</title>
        <p>A fourteen-month-old boy with the diagnosis of gastroesophageal reflux disease was admitted to our hospital with complaints of vomiting and diarrhea for a month. On admission, his physical examination revealed fever (38.4<sup>&#xB0;</sup>C). Because of the prolonged diarrhea and vomiting, patient was hospitalized and further investigated. Laboratory tests showed a WBC of 5800/&#xB5;l, CRP of 3.2 mg/L and normal biochemistry values. Peripheral blood culture was obtained and signaled growth for gram-negative bacilli. Empirical antibiotic treatment with meropenem and amikacin was started. Microorganism was identified as <italic>Acinetobacter ursingii</italic> by Vitek MS (bioMeri&#xE8;ux) with a reliability of 99.9%. The e-test showed that <italic>A. ursingii</italic> was susceptible to ampicilin-sulbactam, gentamicin, ciprofloxacin and imipenem. The antibiotic therapy was deescalated to ampicin-sulbactam. On the third day of the treatment, control peripheral blood culture remained sterile. He was successfully treated with ampicillin-sulbactam.</p>
      </sec>
    </sec>
    <sec sec-type="discussion" id="S0005">
      <title>Discussion</title>
      <p>
<italic>Acinetobacter ursingii</italic> can cause life-threatening bloodstream infection especially in immunocompromised patients, but their correct identification is problematic. Currently, more than 32 genomic species have been identified by molecular methods [<xref rid="CIT0006" ref-type="bibr">6</xref>, <xref rid="CIT0007" ref-type="bibr">7</xref>]. Virulence, epidemiology, antimicrobial susceptibility, clinical significance of <italic>Acinetobacter</italic> species may vary. Therefore, determining the prevalence of the <italic>Acinetobacter</italic> species causing invasive infection may be helpful in the management of infection [<xref rid="CIT0008" ref-type="bibr">8</xref>, <xref rid="CIT0009" ref-type="bibr">9</xref>]. Risk factors for infection with <italic>A. ursingii</italic> emerged as noso-comial pathogens during the last 3 decades including underlying serious disease such as cancer, intravascular catheterization, treatment with broad spectrum antibiotics, prolonged hospitalization. Due to their ability for long-term survival in the environment, <italic>A. ursingii</italic> may spread among patients and cause nosocomial infections and outbreaks. Although <italic>A. ursingii</italic> have low pathogenic potential, it has increasingly been described as opportunistic pathogen particularly in immunosupressed and patients in intensive care units [<xref rid="CIT0010" ref-type="bibr">10</xref>]. <italic>Acinetobacter</italic> may cause suppurative infection such as peritonitis, endocarditis, osteomyelitis, arthritis, pancreatic and liver abcesses. Clinical manifestations are similar to other bacterial infections and may vary depending on the serious underlying disease and immune status. <italic>A. ursingii</italic> related bloodstream infection may occur as primary or secondary to respiratory or urinary tract and wound infection. Immunosupressed neonates are at particularly high risk for primary bacteremia, and clinical signs may vary ranging from an asymptomatic to septic shock and disseminated intravascular coagulation. Because of increasing antibiotic resistance, treatment of infections due to <italic>Acinetobacter spp</italic>. has become difficult. Antibiotic treatment should be determined by in vitro susceptibility testing. <italic>A. ursingii</italic> seems to be more susceptible to antimicrobial agents compared to <italic>A. baumannii</italic>. Infections due to <italic>A. ursingii</italic> are rare in healthy children. There are a few reports of infection with <italic>A. ursingii</italic> in the literature; most of the cases are immunocompromised with underlying serious disease. Report of a bacteremia caused by <italic>A. ursingii</italic> in an adult patient with oro-pharyngeal cancer was reported [<xref rid="CIT0011" ref-type="bibr">11</xref>].</p>
    </sec>
    <sec sec-type="conclusion" id="S0006">
      <title>Conclusion</title>
      <p>Although <italic>A. ursingii</italic>, has recently been isolated from a clinical specimen, reports of infection with <italic>A. ursingii</italic> in children are rare. Our patients had neither of central venous catheter, immuno-compromised status, severe underlying co-morbidities and prolonged hospitalization. Source of <italic>A. ursingii</italic> may either be the hospital or colonization prior to admission. As a conclusion, although rare, <italic>A. ursingii</italic> should be kept in mind as an opportunistic microorganism in children.</p>
    </sec>
  </body>
  <back>
    <sec id="S0007">
      <title>Competing interests</title>
      <p>The authors declare no competing interests.</p>
    </sec>
    <sec id="S0008">
      <title>Authors&#x2019; contributions</title>
      <p>All authors interested in management, treatment and outcome the patient. All authors have been involved in drafting the manuscript or revising critically for important intellectual content. All authors read and approved the final manuscript.</p>
    </sec>
    <ref-list>
      <title>References</title>
      <ref id="CIT0001">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chuang</surname>
              <given-names>YC</given-names>
            </name>
            <name>
              <surname>Sheng</surname>
              <given-names>WH</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>SY</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Influence of genospecies of Acineto-bacterbaumannii complex on clinical outcomes of patients with Acinetobacter bacteremia</article-title>
          <source>Clin Infect Dis</source>
          <year>2011</year>
          <volume>52</volume>
          <issue>3</issue>
          <fpage>352</fpage>
          <lpage>60</lpage>
          <pub-id pub-id-type="pmid">21193494</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0002">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Turton</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Shah</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Ozongwu</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Incidence of Acinetobacter species other than A baumannii among clinical isolates of Acinetobacter: evidence for emerging species</article-title>
          <source>J ClinMicrobiol</source>
          <year>2010</year>
          <volume>48</volume>
          <issue>4</issue>
          <fpage>1445</fpage>
          <lpage>9</lpage>
        </element-citation>
      </ref>
      <ref id="CIT0003">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Seifert</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Dijkshoorn</surname>
              <given-names>LP</given-names>
            </name>
            <name>
              <surname>Gerner-Smidt</surname>
              <given-names>P</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Distribution of Acinetobacter species on human skin: comparison of phenotypic and genotypic identification methods</article-title>
          <source>J Clin Microbiol</source>
          <year>1997</year>
          <volume>35</volume>
          <issue>11</issue>
          <fpage>2819</fpage>
          <lpage>25</lpage>
          <pub-id pub-id-type="pmid">9350741</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0004">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kilic</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Mellmann</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Acineto-bactersepticus sp nov association with a noso-comial outbreak of bacteremia in a neonatal intensive care unit</article-title>
          <source>J Clin Microbiol</source>
          <year>2008</year>
          <volume>46</volume>
          <issue>3</issue>
          <fpage>902</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">18160455</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0005">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nemec</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>De Baere</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Tjernberg</surname>
              <given-names>I</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Acineto-bacterursingii sp nov and Acineto-bacterschindleri sp nov, isolated from human clinical specimens</article-title>
          <source>Int J Syst Evol Microbiol</source>
          <year>2001</year>
          <volume>51</volume>
          <issue>5</issue>
          <fpage>1891</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">11594623</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0006">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Karah</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Haldorsen</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Hegstad</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Norwegian Study Group of Acinetobacter: species identification and molecular characterization of Acinetobacter spp blood culture isolates from Norway</article-title>
          <source>J Antimicrob Chemother</source>
          <year>2011</year>
          <volume>66</volume>
          <issue>4</issue>
          <fpage>738</fpage>
          <lpage>44</lpage>
          <pub-id pub-id-type="pmid">21393175</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0007">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nemec</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Mus&#xED;lek</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Maixnerov&#xE1;</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Acineto-bacterbeijerinckii sp nov and Acineto- bactergyllenbergii sp nov, haemolytic organisms isolated from humans</article-title>
          <source>Int J Syst Evol Microbiol</source>
          <year>2009</year>
          <volume>59</volume>
          <issue>1</issue>
          <fpage>118</fpage>
          <lpage>24</lpage>
          <pub-id pub-id-type="pmid">19126734</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0008">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wisplinghoff</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Paulus</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Lugenheim</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Nosocomial bloodstream infections due to Acineto-bacterbaumannii, Acinetobacterpittii and Acinetobacternosocomialis in the United States</article-title>
          <source>J Infect</source>
          <year>2012</year>
          <volume>64</volume>
          <issue>3</issue>
          <fpage>282</fpage>
          <lpage>90</lpage>
          <pub-id pub-id-type="pmid">22209744</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0009">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lee</surname>
              <given-names>SY</given-names>
            </name>
            <name>
              <surname>Shin</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>KH</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Identification, genotypic relation, and clinical features of colistin-resistant isolates of Acinetobacter genomic species 13BJ/14TU from bloodstreams of patients in a university hospital</article-title>
          <source>J Clin Microbiol</source>
          <year>2014</year>
          <volume>52</volume>
          <issue>3</issue>
          <fpage>931</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">24403305</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0010">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Van den Broek</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Van der Reijden</surname>
              <given-names>TJ</given-names>
            </name>
            <name>
              <surname>Van Strijen</surname>
              <given-names>E</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Endemic and epidemic acinetobacter species in a university hospital: an 8-year survey</article-title>
          <source>J Clin Microbiol</source>
          <year>2009</year>
          <volume>47</volume>
          <issue>11</issue>
          <fpage>3593</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">19794057</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0011">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Endo</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Sasano</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Yano</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>IMP-1-producing carbapenem-resistant Acineto-bacterursingiifrom Japan</article-title>
          <source>J Antimicrob Chemother</source>
          <year>2012</year>
          <volume>67</volume>
          <issue>10</issue>
          <fpage>2533</fpage>
          <lpage>4</lpage>
          <pub-id pub-id-type="pmid">22733654</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
